SPL
Click for more information
2.08% 9.8¢ starpharma holdings limited

Ann: Positive final DEP irinotecan Phase 2 clinical trial results, page-37

  1. Eyeman
    2,539 Posts.
    lightbulb Created with Sketch. 464
    clock Created with Sketch.
    28/05/24
    12:05
    Post #: 74042592
    no mate previous holder who got burnt by the inept ability to commercialise one product and or achieve deadlines - please highlight her commercial successes here for all to read.
    SPL Price at posting: 12.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
AMI First stope ore could be pushed back to Q2 FY25 due to flood-like event: Aurelia
right-arrow Created with Sketch.
NRX Noronex joins forces with South32 to look for copper in Namibia
right-arrow Created with Sketch.
DMP Domino's locks in biggest faller status on Thursday as it closes stores in Asia, Europe
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.8¢ 		Change
0.002(2.08%) 		Mkt cap ! $40.41M
Open High Low Value Volume
10.0¢ 10.0¢ 9.8¢ $2.321K 23.52K

Buyers (Bids)

No. Vol. Price($)
1 2500 9.7¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 9000 2
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.